Longboard Pharmaceuticals Inc LBPH:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
20.51UNCH (UNCH)
Volume
6,068
Close
20.51quote price arrow down-0.63 (-2.98%)
Volume
234,851
52 week range
3.60 - 28.15
Loading...
  • Open21.05
  • Day High21.34
  • Day Low20.25
  • Prev Close21.14
  • 52 Week High28.15
  • 52 Week High Date01/23/24
  • 52 Week Low3.60
  • 52 Week Low Date11/30/23

Key Stats

  • Market Cap797.43M
  • Shares Out38.88M
  • 10 Day Average Volume0.25M
  • Dividend-
  • Dividend Yield-
  • Beta1.55
  • YTD % Change240.13

KEY STATS

  • Open21.05
  • Day High21.34
  • Day Low20.25
  • Prev Close21.14
  • 52 Week High28.15
  • 52 Week High Date01/23/24
  • 52 Week Low3.60
  • 52 Week Low Date11/30/23
  • Market Cap797.43M
  • Shares Out38.88M
  • 10 Day Average Volume0.25M
  • Dividend-
  • Dividend Yield-
  • Beta1.55
  • YTD % Change240.13

RATIOS/PROFITABILITY

  • EPS (TTM)-2.25
  • P/E (TTM)-9.10
  • Fwd P/E (NTM)-11.08
  • EBITDA (TTM)-62.902M
  • ROE (TTM)-30.04%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/01/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Longboard Pharmaceuticals Inc

 

Profile

MORE
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing medicines for neurological diseases. The Company is working to advance a portfolio of centrally acting product candidates designed to be highly selective for specific G protein-coupled receptors (GPCRs). It is focused on developing various product candidates in its pipeline, which includes bexicaserin (LP352) and LP659. The Company plans to advance bexicaserin (LP352), an oral...
Paul Sekhri
Independent Chairman of the Board
Kevin Lind
President, Chief Executive Officer, Director
Brandi Roberts
Chief Financial Officer, Executive Vice President
Randall Kaye M.D.
Executive Vice President, Chief Medical Officer
Address
4275 Executive Square, Suite 950
La Jolla, CA
92037
United States

Top Peers

SYMBOLLASTCHG%CHG
IRON
Disc Medicine Inc
31.92+0.06+0.19%
PLRX
Pliant Therapeutics Inc
15.61+0.25+1.63%
COGT
Cogent Biosciences Inc
7.47-0.25-3.24%
ALXO
ALX Oncology Holdings Inc
14.66-0.36-2.40%
SPRY
ARS Pharmaceuticals Inc
9.10+0.22+2.48%